356 related articles for article (PubMed ID: 12170020)
1. Extended local resection for advanced gastric cancer: increased survival versus increased morbidity.
Martin RC; Jaques DP; Brennan MF; Karpeh M
Ann Surg; 2002 Aug; 236(2):159-65. PubMed ID: 12170020
[TBL] [Abstract][Full Text] [Related]
2. Postoperative morbidity/mortality and survival rates after total gastrectomy, with splenectomy/pancreaticosplenectomy for patients with advanced gastric cancer.
Yamamoto M; Baba H; Kakeji Y; Endo K; Ikeda Y; Toh Y; Kohnoe S; Okamura T; Maehara Y
Hepatogastroenterology; 2004; 51(55):298-302. PubMed ID: 15011889
[TBL] [Abstract][Full Text] [Related]
3. Achieving RO resection for locally advanced gastric cancer: is it worth the risk of multiorgan resection?
Martin RC; Jaques DP; Brennan MF; Karpeh M
J Am Coll Surg; 2002 May; 194(5):568-77. PubMed ID: 12025834
[TBL] [Abstract][Full Text] [Related]
4. Is there a benefit of pancreaticosplenectomy with gastrectomy for advanced gastric cancer?
Kasakura Y; Fujii M; Mochizuki F; Kochi M; Kaiga T
Am J Surg; 2000 Mar; 179(3):237-42. PubMed ID: 10827328
[TBL] [Abstract][Full Text] [Related]
5. Results of combined gastrectomy and pancreatic resection in patients with advanced primary gastric carcinoma.
Piso P; Bellin T; Aselmann H; Bektas H; Schlitt HJ; Klempnauer J
Dig Surg; 2002; 19(4):281-5. PubMed ID: 12207071
[TBL] [Abstract][Full Text] [Related]
6. Extended multiorgan resection for T4 gastric carcinoma: 25-year experience.
Carboni F; Lepiane P; Santoro R; Lorusso R; Mancini P; Sperduti I; Carlini M; Santoro E
J Surg Oncol; 2005 May; 90(2):95-100. PubMed ID: 15844189
[TBL] [Abstract][Full Text] [Related]
7. Higher morbidity and mortality after combined total gastrectomy and pancreaticosplenectomy for gastric cancer.
Lo SS; Wu CW; Shen KH; Hsieh MC; Lui WY
World J Surg; 2002 Jun; 26(6):678-82. PubMed ID: 12053218
[TBL] [Abstract][Full Text] [Related]
8. Impact of spleen preservation in patients with gastric cancer.
Fatouros M; Roukos DH; Lorenz M; Arampatzis I; Hottentrott C; Encke A; Kappas AM
Anticancer Res; 2005; 25(4):3023-30. PubMed ID: 16080561
[TBL] [Abstract][Full Text] [Related]
9. Multi-visceral resection for locally advanced gastric cancer.
Bloechle C; Izbicki JR; Limmer J; Kühn R; Hosch SB; Busch C; Rogiers X; Broelsch CE
Acta Chir Belg; 1995; 95(2):72-5. PubMed ID: 7754735
[TBL] [Abstract][Full Text] [Related]
10. Surgical outcomes and survival after multiorgan resection for locally advanced gastric cancer.
Ozer I; Bostanci EB; Orug T; Ozogul YB; Ulas M; Ercan M; Kece C; Atalay F; Akoglu M
Am J Surg; 2009 Jul; 198(1):25-30. PubMed ID: 18823618
[TBL] [Abstract][Full Text] [Related]
11. Is pancreas and/or spleen resection required in total gastrectomy for advanced gastric cancer?
García Picazo D; Cascales Sánchez P; García Blázquez E; Moreno Resina JM
Rev Esp Enferm Dig; 2001 Jul; 93(7):459-70. PubMed ID: 11685942
[TBL] [Abstract][Full Text] [Related]
12. D2 or not D2? The gastrectomy question.
Lewis WG; Edwards P; Barry JD; Khan S; Dhariwal D; Hodzovic I; Allison MC; Shute K
Gastric Cancer; 2002; 5(1):29-34. PubMed ID: 12021857
[TBL] [Abstract][Full Text] [Related]
13. [Prognosis analysis of surgical treatment for cancer of stomach fundus and cardia with invasion to body and tail of the pancreas].
Huang CM; Lu HS; Li P; Xie JW; Lin BJ; Zhang XF
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):432-5. PubMed ID: 18803043
[TBL] [Abstract][Full Text] [Related]
14. Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups?
Lim S; Muhs BE; Marcus SG; Newman E; Berman RS; Hiotis SP
J Surg Oncol; 2007 Feb; 95(2):118-22. PubMed ID: 17262741
[TBL] [Abstract][Full Text] [Related]
15. Adenocarcinoma of the gastric antrum: does D2 total gastrectomy with splenectomy improve prognosis compared to D1 subtotal gastrectomy? A long-term survival analysis with emphasis on Lauren classification.
Roukos D; Schmidt-Mathiesen A; Encke A
Surg Oncol; 1995; 4(6):323-32. PubMed ID: 8809955
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of radical D2-lymphadenectomy and splenectomy in surgically treated gastric cancer patients.
Schmid A; Thybusch A; Kremer B; Henne-Bruns D
Hepatogastroenterology; 2000; 47(32):579-85. PubMed ID: 10791243
[TBL] [Abstract][Full Text] [Related]
17. Western body mass indices need not compromise outcomes after modified D2 gastrectomy for carcinoma.
Barry JD; Blackshaw GR; Edwards P; Lewis WG; Murphy P; Hodzovic I; Thompson IW; Allison MC
Gastric Cancer; 2003; 6(2):80-5. PubMed ID: 12861398
[TBL] [Abstract][Full Text] [Related]
18. Extended lymph node dissection without routine spleno-pancreatectomy for treatment of gastric cancer: low morbidity and mortality rates in a single center series of 250 patients.
Biffi R; Chiappa A; Luca F; Pozzi S; Lo Faso F; Cenciarelli S; Andreoni B
J Surg Oncol; 2006 Apr; 93(5):394-400. PubMed ID: 16550575
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of combined splenectomy in proximal gastric cancer with No.10 lymph node metastasis].
Wang JB; Huang CM; Lu HS; Zheng CH; Li P; Xie JW; Zhang XF
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Mar; 12(2):121-5. PubMed ID: 19296243
[TBL] [Abstract][Full Text] [Related]
20. Morbidity and mortality rates following gastric cancer surgery and contiguous organ removal, a population based study.
Nanthakumaran S; Fernandes E; Thompson AM; Rapson T; Gilbert FJ; Park KG
Eur J Surg Oncol; 2005 Dec; 31(10):1141-4. PubMed ID: 16111855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
